The incidence of the most common strain of Methicillin-resistant Staphylococcus aureus (MRSA) infections has decreased in hospital-onset cases, but has failed to decline in…
Self-inflicted injury is actually the eighth, not the tenth, leading cause of death, above kidney disease, and pneumonia and influenza, according to a report…
Antibacterial soap containing triclosan (0.3%) is no more effective than plain soap at reducing bacterial contamination, according to a study in the Journal of…
On Sept. 4, the U.S. Food and Drug Administration (FDA) approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria,…
On Sept. 2, the U.S. Food and Drug Administration (FDA) approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting. Read more. On…
On Aug. 31, the American Nurses Association released a new position statement “Incivility, Bullying, and Workplace Violence”. Read more and access the statement.
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.…
The incidence of the most common strain of Methicillin-resistant Staphylococcus aureus (MRSA) infections has decreased in hospital-onset cases, but has failed to…
On Sept. 4, the U.S. Food and Drug Administration (FDA) approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary…
On Sept. 2, the U.S. Food and Drug Administration (FDA) approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting. Read…
On Aug. 31, the American Nurses Association released a new position statement “Incivility, Bullying, and Workplace Violence”. Read more and access the…
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in…